Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
319
NCT01117948
Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2009
Completion: Apr 30, 2011
NCT01533298
A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition
Phase: Phase 3
Start: Jul 31, 2011
Completion: Jan 31, 2012
NCT01533766
A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition
Start: Aug 31, 2011
Completion: Feb 29, 2012